Article: TKT Forms European Company to Market Niche Protein Products -TKT Europe-5S AB Receives Recommendation for European Orphan Drug Designation of Replagal(TM)-.

Article: TKT FORMS EUROPEAN COMPANY TO MARKET NICHE PROTEIN ...
PR Newswire;  July 17, 2000 ;     700+ words ... ... the formation of TKT Europe-5S AB to provide ... distribution for TKT's Niche Protein(TM) products in Europe. TKT Europe-5S, headquartered ... be addressed to TKT Europe - 5S AB, Rinkebyvagen ... TM) proteins, Niche Protein(TM) products ...

Article: TKT Completes Acquisition of Minority Interest in TKT ...
PR Newswire;  October 22, 2004 ;     700+ words ... ... completed the purchase of the 20% equity interest in TKT Europe-5S AB held by the founding European executives of TKT Europe-5S for $61 million. With this purchase, TKT now owns 100% of TKT Europe-5S. The purchase price was based on a predefined ...

Article: Biopharmaceutical company acquires minority interest in ...
Health & Medicine Week;  November 22, 2004 ;     579 words ... ... completed the purchase of the 20% equity interest in TKT Europe-5S AB held by the founding European executives of TKT Europe-5S for $61 million. With this purchase, TKT now owns 100% of TKT Europe-5S. The purchase price was based on a predefined ...

Article: TKT completes buy of minority holding in TKT ...
Pharma Marketletter;  November 1, 2004 ;     644 words ... ... purchase of the 20% equity interest in TKT Europe-5S AB held by the founding European ... this purchase, TKT now owns 100% of TKT Europe-5S. The purchase price was based on ... company will account for the acquisition of TKT Europe-5S's minority interest as a step ...

Article: TKT Announces Acceptance of MAA in Europe for Replagal(TM) for ...
PR Newswire;  July 19, 2000 ;     700+ words ... ... announced the formation of TKT Europe-5S AB, based in Sweden ... distribution for the Company's Niche Protein products in Europe. TKT Europe-5S AB will operate under ... Activated(TM) proteins, Niche Protein(TM) products, and Gene ...

Article: TKT'S REPLAGAL RECEIVES RECOMMENDATION FOR APPROVAL IN EUROPEAN ...
PR Newswire;  March 28, 2001 ;     700+ words ... ... expected mid-year, TKT Europe-5S will launch and market Replagal in Europe. TKT Europe-5S, based in Sweden ... distribution for TKT's Niche Protein(TM) products in Europe. Over the past year, TKT Europe-5S has played a crucial ...

Article: FIRST TREATMENT AVAILABLE FOR PEOPLE WITH DEBILITATING DISEASE.
PR Newswire;  August 3, 2001 ;     700+ words ... ... transmitted on behalf of TKT Europe-5S AB. TKT Europe ... About the company TKT Europe-5S AB is a pharmaceutical ... European countries. TKT Europe-5S AB has a close ... Activated proteins, Niche Protein products and Gene Therapy ...